Streetbeat News

Products Services

BRTX

BioRestorative Therapies has announced that the final subject in its BRTX-100 Phase 2 clinical trial safety cohort has been dosed.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 10:30 am

GM

NFLX

NVDA

TSLA

The S&P 500 reached new highs, surpassing the 4,300 level for the first time since August. Tesla and General Motors announced a partnership for GM cars to use Tesla charging stations by 2025. Netflix shares gained 2.6% after a report on increased subscriptions due to its password sharing crackdown. The Nasdaq 100 rose 0.30% with gains in NVIDIA and Tesla shares.

Portfolio Pulse from Lisa Levin

June 12, 2023 | 10:07 am

NIO

TSLA

Chinese EV maker Nio announced price cuts on all its new models and discontinuation of free battery exchange service for new users, following a Q1 FY23 sales growth of 7.7% YoY to $1.56 billion, missing the consensus of $1.63 billion. Vehicle sales declined and vehicle margin contracted 1,300 basis points to 5.1%.

Portfolio Pulse from Anan Ashraf

June 12, 2023 | 8:57 am

XPEV

XPeng's shares rose 9.5% in premarket trading after the company announced receiving over 25,000 orders for its G6 model within 72 hours of the pre-sale launch.

Portfolio Pulse from Charles Gross

June 12, 2023 | 8:50 am

AZN

BNTX

FXI

JNJ

MRNA

NVAX

PFE

China's latest Covid-19 wave has peaked with around 2,800 severe cases and 164 deaths, according to the South China Morning Post. The news may impact the stocks of vaccine manufacturers and China-related ETFs.

Portfolio Pulse from Charles Gross

June 12, 2023 | 8:43 am

NIO

China's electric vehicle maker Nio announced a price cut of approximately $4,200 for all models starting June 12, as reported by Reuters.

Portfolio Pulse from Charles Gross

June 12, 2023 | 8:37 am

KURA

Kura Oncology announced updated clinical data from the KOMET-001 Phase 1/2 trial of Ziftomenib, showing significant clinical activity in patients with heavily pretreated and co-mutated relapsed/refractory NPM1-mutant acute myeloid leukemia.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 8:36 am

AZN

AZNCF

The FDA has granted priority review to AstraZeneca's Capivasertib plus Faslodex for hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced/metastatic breast cancer. The regulatory decision is expected in Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 8:29 am

PSNY

RIVN

TSLA

YouTuber Marques Brownlee named Polestar (NASDAQ:PSNY) as one of his favorite cars under $55,000 in a recent interview. He also mentioned Kia EV-6 GT as a second favorite. Polestar reported 12,076 deliveries in Q1, up 26% YoY, but delayed the start of production for Polestar 3 and cut production forecasts for 2023.

Portfolio Pulse from Anan Ashraf

June 12, 2023 | 7:09 am

AAPL

Apple is reportedly working on an immersive TV show experience called 'Monarch: Legacy of Monsters' for its Vision Pro mixed-reality headset. The show will be set in the Monsterverse and feature Godzilla. The exact premiere date remains undisclosed.

Portfolio Pulse from Ananya Gairola

June 12, 2023 | 6:06 am